Singapore Scientists Find Protein That Reverses Brain Aging

Scientists in Singapore just found a biological switch that could help aging brains stay sharp.

Researchers at the National University of Singapore identified a protein called DMTF1 that acts like a restart button for tired brain cells. When levels of this protein drop, our neural stem cells lose their ability to create the new neurons we need for learning and memory.

The discovery came from studying both human cells and lab models designed to show premature aging. Assistant Professor Ong Sek Tong Derrick and his team wanted to understand why our brains slow down as we get older, particularly why stem cells stop producing fresh neurons.

They found something remarkable. In aged neural stem cells, DMTF1 levels had dropped significantly. But when researchers boosted the protein back to normal levels, those tired cells sprang back to life and started regenerating again.

The protein works by unlocking tightly packed DNA, allowing genes related to cell growth to switch on. It controls helper genes called Arid2 and Ss18, which loosen the DNA's structure so stem cells can renew themselves properly.

The breakthrough matters because neural stem cell decline has puzzled scientists for years. While researchers knew these cells weakened with age, they didn't fully understand why or how to fix it. This discovery provides the missing piece.

The team focused on telomeres, the protective caps on our chromosomes that shorten each time cells divide. As telomeres shrink, cells age and lose function. The researchers found that DMTF1 can restore regeneration even when these protective caps have worn down.

The Bright Side

This isn't just about understanding aging better. The findings point toward real treatments that could slow or even reverse cognitive decline.

The research team plans to test whether boosting DMTF1 can increase neural stem cell numbers and improve learning and memory in aging conditions. They're being careful to ensure any future treatments won't increase brain tumor risk.

Their next step involves identifying small molecules that can safely stimulate DMTF1 activity. These molecules could eventually become medications that rejuvenate aging neural stem cells.

Dr. Liang Yajing, the study's first author, emphasized that while the research is still early, it creates a framework for developing actual therapies. The team published their findings in Science Advances, giving other researchers worldwide a roadmap to build on.

The work represents hope for millions facing age-related cognitive decline, transforming what once seemed inevitable into something we might actually prevent.